| a1AT | alpha 1-antitrypsin |
| APOA1 | apolipoprotein A1 |
| APOA4 | apolipoprotein A4 |
| APOL1 | apolipoprotein L1 |
| AUC | area under the curve |
| C3 | complement C3 |
| C4a | complement C4a |
| C5 | complement component 5 |
| CA | correct assignment |
| CFH | complement factor H |
| D2G | DBA/2J-Gpnmb+/SjJ mice strain without signs of glaucoma |
| DBA/2J_G | DBA/2J mice that developed glaucoma with the age |
| DBA/2J_NG | DBA/2J mice that did not develop glaucoma |
| FCN3 | ficolin-3 |
| GPNMB | transmembrane glycoprotein NMB |
| IOP | intraocular pressure |
| IPD | iris pigment dispersion |
| ISA | iris stromal atrophy |
| ITIH4 | inter-alpha-trypsin inhibitor heavy chain H4 |
| MOD | nerves with moderate damage |
| NOE | nerves with neither or early damage |
| PEXG | pseudoexfoliation glaucoma |
| POAG | Primary open-angle glaucoma |
| PPD | paraphenylenediamine |
| PPI | protein–protein interaction |
| Prec. | precision |
| RGC | retinal ganglion cell |
| Sens. | sensitivity |
| SEV | nerves with severe glaucoma |
| Spec. | specificity |
| TTR | transthyretin |